USA Authorized Femicore Retailer Lot FEM-26/FE-3921 One capsule daily · 30 per bottle 60-day money-back guarantee
FemiCoreFemicoredaily

Femicore Official Website › Disclaimer

Disclosures

Femicore Disclaimer: Medical, Results, Evidence And Affiliate

Quick answer

Femicore is a dietary supplement, not a drug, and it is not FDA-approved. These statements have not been evaluated by the Food and Drug Administration and this product is not intended to diagnose, treat, cure or prevent any disease. The research cited on this website concerns individual ingredients at doses this label does not publish. This desk earns on orders placed through it.

Four disclosures, each written out rather than compressed into a sentence nobody reads.

Medical

Femicore is not medical advice or medical treatment

Nothing on this website is medical advice. Nobody at this desk is a clinician and no page here is a substitute for one.

Femicore is a dietary supplement. It is not a drug. It is not FDA-approved, and no dietary supplement is; the FDA-registered facility mark on the label is a statement about a building rather than about a formula, and it is explained on the quality page.

It does not treat a urinary tract infection. An infection is an infection and is treated with antibiotics. NIDDK sets out what a bladder infection is. Burning, fever, back or flank pain, blood in the urine, or symptoms that worsen over a day or two mean calling a doctor, not ordering a capsule.

It does not treat incontinence. Pelvic floor muscle training is the first-line treatment for stress incontinence in women and it has a Cochrane review behind it. NIDDK and the Office on Women’s Health both publish free pages on bladder control that are more useful than any supplement page, including this one.

Talk to a clinician before starting, if you take anything on prescription. The berberine on this panel inhibits CYP3A4 and P-glycoprotein (Qiu 2009), which between them clear a great many medicines. That conversation takes five minutes and it is set out on the side effects page.

The statement

The FDA disclosure printed on every Femicore page

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

That sentence is printed on the bottle and it appears in the footer of every page on this website. It is not decorative. It is the statement a dietary supplement is required to carry alongside the kind of claims this label makes, and the three lines on the front of the bottle each carry a dagger pointing at it.

Results

What Femicore testimonials are and are not

Every review published on this website is buyer-supplied. They describe those individuals’ own experiences, they are not typical results, and they are not evidence that the product works.

The record this desk holds is 4.7 out of 5 from 739 written reviews across 9,675 orders, with 86% saying they would recommend it. Roughly one buyer in seven would not. Eight reviewers are held in detail and they carry two review sentences between them, which makes those sentences summary categories rather than transcripts; the reviews page publishes them as counted themes for exactly that reason, and the reviewer first names are withheld.

Individual results vary, and so does everything around them. Fluid intake, sleep, weight, childbirth history, menopause status and any prescribed treatment all affect the things this capsule is sold to support, and none of them is controlled for in a review.

Evidence

What the research cited on this Femicore website actually shows

Femicore has never been tested in a clinical trial. Not once, as a finished capsule. Every study cited anywhere on this website concerns one ingredient or one strain.

None of those studies can be matched to this capsule. The panel publishes two blend totals, 350 mg and 50 mg, and no amount for any of the nine names inside them, and no colony count for any strain. A trial that used 37 mg of proanthocyanidin tells you about 37 mg of proanthocyanidin.

Two of the studies used a different route entirely. The Lactobacillus crispatus trials most often quoted for this kind of product (Stapleton 2011 and Cohen 2020) delivered the strain intravaginally as a suppository. This is a capsule you swallow.

Some of the evidence cuts against the product. The Cochrane review of cranberry as a treatment did not support it, and the uva-ursi trial against fosfomycin did not find the herb a satisfactory substitute for the antibiotic. Both are cited here rather than quietly left out.

The citations exist so a reader can see the size of the gap rather than to suggest the capsule inherits the findings.

Money

How this Femicore website earns

Femicoredaily earns on orders placed through the checkout reached from this website. That is a direct commercial interest in your decision and it should be weighed against everything on these pages.

The way to weigh it is to look at the places where this website argued against its own revenue: recommending three bottles rather than six, publishing the missing-amounts table, declining three of the seller’s own claims, printing the berberine interaction list with an instruction to speak to a pharmacist first, and publishing the contradiction between the vegetarian badge and the gelatin capsule. Those six are listed with links on the about page.

Not everyone

Groups this website does not intend Femicore pages for

  • ✓Anyone under 18. The printed caution names children under the age of 18 and this website is not directed at them.
  • ✓Anyone pregnant or nursing. The same caution tells both groups to consult a physician before using this or any dietary supplement, and nothing on these pages softens that.
  • ✓Anyone with symptoms of an active infection. Burning, fever, back or flank pain or blood in the urine mean a doctor, and these pages should not be the thing standing between you and that call.
  • ✓Anyone using this instead of a prescribed treatment. A supplement is an addition at most. Stopping something a clinician prescribed because of anything read here would be a misuse of every page on this website.
  • ✓Anyone outside the United States looking for regulatory guidance. These pages describe a product sold under United States rules. Supplement law differs considerably elsewhere and nothing here is written for another jurisdiction.
Images and trademarks

The Femicore images used on this website

The product photographs, the label artwork, the badge set and the promotional scenes on this website are the manufacturer’s, supplied to this desk for the purpose of selling the product. FemiCore and the bottle design belong to their owner.

Every one of them is published here with a caption that says what it shows and, where relevant, what it does not. That is a deliberate policy rather than a style preference: vendor artwork states claims, and a caption is the natural place to test them. Where an image cannot be used honestly as it stands, it is published with the mismatch as the content rather than dropped, which is what happened to the vegetarian badge on the quality page.

Who writes this

Who maintains the Femicore disclaimer

This desk publishes what the bottle says and marks the gaps. The four claims below are the ones a sceptical reader can audit in ten minutes, which is the only reason worth making them:

  1. The printed panel is the source. The three claim lines, the two blend totals, the nine names, the capsule count and the serving instruction are read off the FemiCore label photograph in our own asset folder, not from a review column and not from a summary.
  2. Not published stays not published. This panel prints 350 mg for the herbal blend and 50 mg for the probiotic blend and no amount for any of the nine names inside them. It prints no colony count for any strain. Nothing undisclosed is estimated anywhere on this website, including in the structured data a machine reads.
  3. Sources are real and linked in the sentence. Every study cited here was confirmed against its PubMed record through the NCBI programming interface before it was written down, and every government page was checked against its own site root first, because two of these hosts refuse a non-browser client in a way that looks exactly like a dead link.
  4. Corrections change the date. Write to [email protected] and the review date at the foot of the page moves forward with the fix.

We earn when you buy. Femicoredaily is the Femicore retail desk named at the top of this page, and this website makes money on orders placed through it. That is exactly why the missing-amounts table, the bearberry duration limit, the berberine interaction list and the page recommending the three-bottle pack over the six are here. They are where our interest and yours pull apart, and you should be able to watch us choose.

The desk on +1 (302) 200-3480 handles tracking, address changes and refunds, which is real service and worth having. It is not a sales line, and this website never presents it as a way to place an order. Orders go through the checkout only.

Sources

Sources cited in the Femicore disclaimer

  1. National Institute of Diabetes and Digestive and Kidney Diseases. Bladder Infection (Urinary Tract Infection — UTI) in Adults. https://www.niddk.nih.gov/health-information/urologic-diseases/bladder-infection-uti-in-adults
  2. National Institute of Diabetes and Digestive and Kidney Diseases. Bladder Control Problems (Urinary Incontinence). https://www.niddk.nih.gov/health-information/urologic-diseases/bladder-control-problems
  3. Office on Women's Health, US Department of Health and Human Services. Urinary incontinence. https://www.womenshealth.gov/a-z-topics/urinary-incontinence
  4. MedlinePlus, US National Library of Medicine. Urinary Incontinence. https://medlineplus.gov/urinaryincontinence.html
  5. Dumoulin C, Cacciari LP, Hay-Smith EJC. Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women. Cochrane Database Syst Rev. 2018;10(10):CD005654. https://pubmed.ncbi.nlm.nih.gov/30288727/
  6. Qiu W, Jiang XH, Liu CX, Ju Y, Jin JX. Effect of berberine on the pharmacokinetics of substrates of CYP3A and P-gp. Phytother Res. 2009;23(11):1553-8. https://pubmed.ncbi.nlm.nih.gov/19370549/
  7. Stapleton AE, Au-Yeung M, Hooton TM, et al. Randomized, placebo-controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection. Clin Infect Dis. 2011;52(10):1212-7. https://pubmed.ncbi.nlm.nih.gov/21498386/
  8. Cohen CR, Wierzbicki MR, French AL, et al. Randomized trial of Lactin-V to prevent recurrence of bacterial vaginosis. N Engl J Med. 2020;382(20):1906-1915. https://pubmed.ncbi.nlm.nih.gov/32402161/
  9. Jepson RG, Mihaljevic L, Craig JC. Cranberries for treating urinary tract infections. Cochrane Database Syst Rev. 2023;12(12):CD001322. https://pubmed.ncbi.nlm.nih.gov/38096261/
  10. Gágyor I, Hummers E, Schmiemann G, et al. Herbal treatment with uva ursi extract versus fosfomycin in women with uncomplicated urinary tract infection in primary care: a randomized controlled trial. Clin Microbiol Infect. 2021;27(10):1441-1447. https://pubmed.ncbi.nlm.nih.gov/34111592/
  11. National Center for Complementary and Integrative Health. Probiotics: What You Need To Know. https://www.nccih.nih.gov/health/probiotics-what-you-need-to-know
Femicore six-bottle order, front labels reading 30 capsules a bottle

Order Femicore with every disclosure already made

Not a drug, not FDA-approved, never trialled as a finished product, and a desk that earns when you buy. All four stated before the button.

From $49 a bottle · 60 days to change your mind

Order Femicore On The Official Website

One-time payment, no subscription · 60-day money-back guarantee · lot FEM-26/FE-3921 · tracking and refunds on +1 (302) 200-3480

Femicore · official website From $49 a bottle · one capsule daily · 60-day guarantee
Order Now